{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:24:02Z","timestamp":1791501842987,"version":"4.3.4"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T00:00:00Z","timestamp":1656374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T00:00:00Z","timestamp":1656374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s00467-022-05639-6","type":"journal-article","created":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T10:16:52Z","timestamp":1656411412000},"page":"2975-2984","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Clinical practice guidelines for nephrotic syndrome: consensus is emerging"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9566-3370","authenticated-orcid":false,"given":"Aditi","family":"Sinha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7832-684X","authenticated-orcid":false,"given":"Arvind","family":"Bagga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,28]]},"reference":[{"key":"5639_CR1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-029249","volume":"148","author":"F Veltkamp","year":"2021","unstructured":"Veltkamp F, Rensma LR, Bouts AHM, LEARNS consortium, (2021) Incidence and relapse of idiopathic nephrotic syndrome: meta-analysis. Pediatrics 148:e2020029249. https:\/\/doi.org\/10.1542\/peds.2020-029249","journal-title":"Pediatrics"},{"key":"5639_CR2","doi-asserted-by":"crossref","unstructured":"(1981) The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisolone. A report of the International Study of Kidney Disease in Children. J Pediatr 98:561\u2013564","DOI":"10.1016\/S0022-3476(81)80760-3"},{"key":"5639_CR3","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s13312-021-2217-3","volume":"58","author":"Sinha A, Bagga A, Banerjee S, Mishra K, Mehta A, Agarwal I, Uthup S, Saha A, Mishra OP; Expert Group of Indian Society of Pediatric Nephrology","year":"2021","unstructured":"Sinha A, Bagga A, Banerjee S, Mishra K, Mehta A, Agarwal I, Uthup S, Saha A, Mishra OP; Expert Group of Indian Society of Pediatric Nephrology (2021) Steroid sensitive nephrotic syndrome: revised guidelines. Indian Pediatr 58:461\u2013481","journal-title":"Indian Pediatr"},{"key":"5639_CR4","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1007\/s13312-021-2262-y","volume":"58","author":"Vasudevan A, Thergaonkar R, Mantan M, Sharma J, Khandelwal P, Hari P, Sinha A, Bagga A; Expert group of the Indian Society of Pediatric Nephrology","year":"2021","unstructured":"Vasudevan A, Thergaonkar R, Mantan M, Sharma J, Khandelwal P, Hari P, Sinha A, Bagga A; Expert group of the Indian Society of Pediatric Nephrology (2021) Consensus guidelines on management of steroid-resistant nephrotic syndrome. Indian Pediatr 58:650\u2013666","journal-title":"Indian Pediatr"},{"key":"5639_CR5","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1007\/s00467-020-04519-1","volume":"35","author":"Trautmann A, Vivarelli M, Samuel S, Gipson D, Sinha A, Schaefer F, Hui NK, Boyer O, Saleem MA, Feltran L, M\u00fcller-Deile J, Becker JU, Cano F, Xu H, Lim YN, Smoyer W, Anochie I, Nakanishi K, Hodson E, Haffner D; International Pediatric Nephrology Association","year":"2020","unstructured":"Trautmann A, Vivarelli M, Samuel S, Gipson D, Sinha A, Schaefer F, Hui NK, Boyer O, Saleem MA, Feltran L, M\u00fcller-Deile J, Becker JU, Cano F, Xu H, Lim YN, Smoyer W, Anochie I, Nakanishi K, Hodson E, Haffner D; International Pediatric Nephrology Association (2020) IPNA clinical practice recommendations for the diagnosis and management of children with steroid-resistant nephrotic syndrome. Pediatr Nephrol 35:1529\u20131561","journal-title":"Pediatr Nephrol"},{"key":"5639_CR6","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","volume":"100","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group","year":"2021","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group (2021) KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int 100:S1\u2013S276","journal-title":"Kidney Int"},{"key":"5639_CR7","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1007\/s00467-021-05135-3","volume":"36","author":"Ehren R, Benz MR, Brinkk\u00f6tter PT, D\u00f6tsch J, Eberl WR, Gellermann J, Hoyer PF, Jordans I, Kamrath C, Kemper MJ, Latta K, M\u00fcller D, Oh J, T\u00f6nshoff B, Weber S, Weber LT; German Society for Pediatric Nephrology","year":"2021","unstructured":"Ehren R, Benz MR, Brinkk\u00f6tter PT, D\u00f6tsch J, Eberl WR, Gellermann J, Hoyer PF, Jordans I, Kamrath C, Kemper MJ, Latta K, M\u00fcller D, Oh J, T\u00f6nshoff B, Weber S, Weber LT; German Society for Pediatric Nephrology (2021) Pediatric idiopathic steroid-sensitive nephrotic syndrome: diagnosis and therapy - short version of the updated German best practice guideline (S2e) - AWMF register no. 166\u2013001, 6\/2020. Pediatr Nephrol 36:2971\u20132985","journal-title":"Pediatr Nephrol"},{"key":"5639_CR8","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1681\/ASN.2012070646","volume":"24","author":"N Teeninga","year":"2013","unstructured":"Teeninga N, Kist-van Holthe JE, van Rijswijk N, de Mos NI et al (2013) Extending prednisolone treatment does not reduce relapses in childhood nephrotic syndrome. J Am Soc Nephrol 24:149\u2013159","journal-title":"J Am Soc Nephrol"},{"key":"5639_CR9","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/ki.2014.240","volume":"87","author":"A Sinha","year":"2015","unstructured":"Sinha A, Saha A, Kumar M, Sharma S, Afzal K, Mehta A, Kalaivani M, Hari P, Bagga A (2015) Extending initial prednisolone treatment in a randomized control trial from 3 to 6 months did not significantly influence the course of illness in children with steroid-sensitive nephrotic syndrome. Kidney Int 87:217\u2013224","journal-title":"Kidney Int"},{"key":"5639_CR10","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/ki.2014.260","volume":"87","author":"Yoshikawa N, Nakanishi K, Sako M, Oba MS, Mori R, Ota E, Ishikura K, Hataya H, Honda M, Ito S, Shima Y, Kaito H, Nozu K, Nakamura H, Igarashi T, Ohashi Y, Iijima K; Japanese Study Group of Kidney Disease in Children","year":"2015","unstructured":"Yoshikawa N, Nakanishi K, Sako M, Oba MS, Mori R, Ota E, Ishikura K, Hataya H, Honda M, Ito S, Shima Y, Kaito H, Nozu K, Nakamura H, Igarashi T, Ohashi Y, Iijima K; Japanese Study Group of Kidney Disease in Children (2015) A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment. Kidney Int 87:225\u2013232","journal-title":"Kidney Int"},{"key":"5639_CR11","volume":"365","author":"Webb NJA, Woolley RL, Lambe T, Frew E, Brettell EA, Barsoum EN, Trompeter RS, Cummins C, Deeks JJ, Wheatley K, Ives NJ; PREDNOS Collaborative Group","year":"2019","unstructured":"Webb NJA, Woolley RL, Lambe T, Frew E, Brettell EA, Barsoum EN, Trompeter RS, Cummins C, Deeks JJ, Wheatley K, Ives NJ; PREDNOS Collaborative Group (2019) Long term tapering versus standard prednisolone treatment for first episode of childhood nephrotic syndrome: phase III randomized controlled trial and economic evaluation. BMJ 365:l1800","journal-title":"BMJ"},{"key":"5639_CR12","doi-asserted-by":"crossref","unstructured":"Hahn D, Samuel SM, Willis NS, Craig JC, Hodson EM (2015) Corticosteroid therapy for nephrotic syndrome in children. Cochrane Database Syst Rev 2015:CD001533","DOI":"10.1002\/14651858.CD001533.pub5"},{"key":"5639_CR13","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.1007\/s00431-021-04035-w","volume":"180","author":"AM Schijvens","year":"2021","unstructured":"Schijvens AM, Teeninga N, Dorresteijn EM, Teerenstra S, Webb NJ, Schreuder MF (2021) Steroid treatment for the first episode of childhood nephrotic syndrome: comparison of the 8 and 12 weeks regimen using an individual patient data meta-analysis. Eur J Pediatr 180:2849\u20132859","journal-title":"Eur J Pediatr"},{"key":"5639_CR14","doi-asserted-by":"crossref","unstructured":"Sinha A, Hari P, Bagga A (2021) Randomized controlled trial comparing 3- vs. 6-months initial prednisone therapy in young children (<4-year-old) with nephrotic syndrome. Abstract presented at ASN Kidney Week. https:\/\/www.asn-online.org\/education\/kidneyweek\/archives\/KW21Abstracts.pdf","DOI":"10.1681\/ASN.20213210S1B1b"},{"key":"5639_CR15","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00467-021-04985-1","volume":"37","author":"MT Christian","year":"2022","unstructured":"Christian MT, Maxted AP (2022) Optimizing the corticosteroid dose in steroid-sensitive nephrotic syndrome. Pediatr Nephrol 37:37\u201347","journal-title":"Pediatr Nephrol"},{"key":"5639_CR16","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s004670050344","volume":"11","author":"BK Ekka","year":"1997","unstructured":"Ekka BK, Bagga A, Srivastava RN (1997) Single- versus divided-dose prednisolone therapy for relapses of nephrotic syndrome. Pediatr Nephrol 11:597\u2013599","journal-title":"Pediatr Nephrol"},{"key":"5639_CR17","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s10157-014-1030-x","volume":"19","author":"K Ishikura","year":"2015","unstructured":"Ishikura K, Matsumoto S, Sako M, Tsuruga K et al (2015) Japanese Society for Pediatric Nephrology; Japanese Society for Pediatric Nephrology (2015) Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: medical therapy. Clin Exp Nephrol 19:6\u201333","journal-title":"Clin Exp Nephrol"},{"key":"5639_CR18","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.kint.2020.09.024","volume":"99","author":"A Gargiulo","year":"2021","unstructured":"Gargiulo A, Massella L, Ruggiero B, Rav\u00e0 L et al (2021) Results of the PROPINE randomized controlled study suggest tapering of prednisone treatment for relapses of steroid sensitive nephrotic syndrome is not necessary in children. Kidney Int 99:475\u2013483","journal-title":"Kidney Int"},{"key":"5639_CR19","doi-asserted-by":"publisher","first-page":"225","DOI":"10.2215\/CJN.06140420","volume":"16","author":"D Kainth","year":"2021","unstructured":"Kainth D, Hari P, Sinha A, Pandey S, Bagga A (2021) Short-duration prednisolone in children with nephrotic syndrome relapse: a noninferiority randomized controlled trial. Clin J Am Soc Nephrol 16:225\u2013232","journal-title":"Clin J Am Soc Nephrol"},{"key":"5639_CR20","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1007\/s00467-021-05048-1","volume":"36","author":"S Sheikh","year":"2021","unstructured":"Sheikh S, Mishra K, Kumar M (2021) Low versus conventional dose prednisolone for nephrotic syndrome relapses: randomized-controlled, non-inferiority-trial. Pediatr Nephrol 36:3143\u20133150","journal-title":"Pediatr Nephrol"},{"key":"5639_CR21","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/j.ekir.2019.08.019","volume":"4","author":"GJ Oh","year":"2019","unstructured":"Oh GJ, Waldo A, Paez-Cruz F, Gipson PE et al (2019) Steroid-associated side effects in patients with primary proteinuric kidney disease. Kidney Int Rep 4:1608\u20131616","journal-title":"Kidney Int Rep"},{"key":"5639_CR22","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1001\/jamapediatrics.2021.5189","volume":"176","author":"MT Christian","year":"2022","unstructured":"Christian MT, Webb NJA, Mehta S, Woolley RL et al (2022) Evaluation of daily low-dose prednisolone during upper respiratory tract infection to prevent relapse in children with relapsing steroid-sensitive nephrotic syndrome: the PREDNOS 2 randomized clinical trial. JAMA Pediatr 176:236\u2013243","journal-title":"JAMA Pediatr"},{"key":"5639_CR23","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/BF00878359","volume":"6","author":"RN Srivastava","year":"1992","unstructured":"Srivastava RN, Vasudev AS, Bagga A, Sunderam KR (1992) Long-term, low-dose prednisolone therapy in frequently relapsing nephrotic syndrome. Pediatr Nephrol 6:247\u2013250","journal-title":"Pediatr Nephrol"},{"key":"5639_CR24","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s00467-018-4071-7","volume":"34","author":"M Yadav","year":"2019","unstructured":"Yadav M, Sinha A, Khandelwal P, Hari P, Bagga A (2019) Efficacy of low-dose daily versus alternate-day prednisolone in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial. Pediatr Nephrol 34:829\u2013835","journal-title":"Pediatr Nephrol"},{"key":"5639_CR25","doi-asserted-by":"crossref","unstructured":"Larkins NG, Liu ID, Willis NS, Craig JC, Hodson EM (2020) Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children. Cochrane Database Syst Rev 4:CD002290","DOI":"10.1002\/14651858.CD002290.pub5"},{"key":"5639_CR26","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1136\/jim-2016-000163","volume":"65","author":"HD Fu","year":"2017","unstructured":"Fu HD, Qian GL, Jiang ZY (2017) Comparison of second-line immunosuppressants for childhood refractory nephrotic syndrome: a systematic review and network meta-analysis. J Investig Med 65:65\u201371","journal-title":"J Investig Med"},{"key":"5639_CR27","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.kint.2017.08.011","volume":"93","author":"Gruppen MP, Bouts AH, Jansen-van der Weide MC, Weide MC, Merkus MP, Zurowska A, Maternik M, Massella L, Emma F, Niaudet P, Cornelissen EAM, Schurmans T, Raes A, van de Walle J, van Dyck M, Gulati A, Bagga A, Davin JC; all members of the Levamisole Study Group","year":"2018","unstructured":"Gruppen MP, Bouts AH, Jansen-van der Weide MC, Weide MC, Merkus MP, Zurowska A, Maternik M, Massella L, Emma F, Niaudet P, Cornelissen EAM, Schurmans T, Raes A, van de Walle J, van Dyck M, Gulati A, Bagga A, Davin JC; all members of the Levamisole Study Group (2018) A randomized clinical trial indicates that levamisole increases the time to relapse in children with steroid-sensitive idiopathic nephrotic syndrome. Kidney Int 93:510\u2013518","journal-title":"Kidney Int"},{"key":"5639_CR28","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s004670000523","volume":"16","author":"K Latta","year":"2001","unstructured":"Latta K, von Schnakenburg C, Ehrich JH (2001) A meta-analysis of cytotoxic treatment for frequently relapsing nephrotic syndrome in children. Pediatr Nephrol 16:271\u2013282","journal-title":"Pediatr Nephrol"},{"key":"5639_CR29","first-page":"221","volume":"94","author":"M Jellouli","year":"2016","unstructured":"Jellouli M, Fitouhi S, Abidi K, Hammi Y, Naija O, Zarrouk C, Gargah T (2016) Mycophenolate mofetil in treatment of childhood steroid-dependent nephrotic syndrome. Tunis Med 94:221\u2013225","journal-title":"Tunis Med"},{"key":"5639_CR30","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.kint.2018.08.039","volume":"95","author":"A Sinha","year":"2019","unstructured":"Sinha A, Puraswani M, Kalaivani M, Goyal P, Hari P, Bagga A (2019) Efficacy and safety of mycophenolate mofetil versus levamisole in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial. Kidney Int 95:210\u2013218","journal-title":"Kidney Int"},{"key":"5639_CR31","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1007\/s00467-018-3970-y","volume":"33","author":"U Querfeld","year":"2018","unstructured":"Querfeld U, Weber LT (2018) Mycophenolate mofetil for sustained remission in nephrotic syndrome. Pediatr Nephrol 33:2253\u20132265","journal-title":"Pediatr Nephrol"},{"key":"5639_CR32","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/nrneph.2012.289","volume":"9","author":"A Sinha","year":"2013","unstructured":"Sinha A, Bagga A (2013) Rituximab therapy in nephrotic syndrome: implications for patients\u2019 management. Nat Rev Nephrol 9:154\u2013169","journal-title":"Nat Rev Nephrol"},{"key":"5639_CR33","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.3389\/fimmu.2019.01653","volume":"10","author":"M Colucci","year":"2019","unstructured":"Colucci M, Carsetti R, Serafinelli J, Rocca S et al (2019) Prolonged impairment of immunological memory after anti-CD20 treatment in pediatric idiopathic nephrotic syndrome. Front Immunol 10:1653. https:\/\/doi.org\/10.3389\/fimmu.2019.01653","journal-title":"Front Immunol"},{"key":"5639_CR34","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s12072-017-9817-y","volume":"11","author":"Z Tang","year":"2017","unstructured":"Tang Z, Li X, Wu S, Liu Y, Qiao Y, Xu D, Li J (2017) Risk of hepatitis B reactivation in HBsAg-negative\/HBcAb-positive patients with undetectable serum HBV DNA after treatment with rituximab for lymphoma: a meta-analysis. Hepatol Int 11:429\u2013433","journal-title":"Hepatol Int"},{"key":"5639_CR35","doi-asserted-by":"publisher","unstructured":"Chan E, Yu E, Angeletti A, Arslan Z et al (2022) Long-term efficacy and safety of repeated rituximab to maintain remission in idiopathic childhood nephrotic syndrome: an international study. J Am Soc Nephrol. https:\/\/doi.org\/10.1681\/ASN.2021111472","DOI":"10.1681\/ASN.2021111472"},{"key":"5639_CR36","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s13312-012-0220-4","volume":"49","author":"A Sinha","year":"2012","unstructured":"Sinha A, Hari P, Sharma PK, Gulati A, Kalaivani M, Mantan M, Dinda AK, Srivastava RN, Bagga A (2012) Disease course in steroid sensitive nephrotic syndrome. Indian Pediatr 49:881\u2013887","journal-title":"Indian Pediatr"},{"key":"5639_CR37","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1007\/s00467-020-04773-3","volume":"36","author":"DM Marchel","year":"2021","unstructured":"Marchel DM, Gipson DS (2021) Adult survivors of idiopathic childhood onset nephrotic syndrome. Pediatr Nephrol 36:1731\u20131737","journal-title":"Pediatr Nephrol"},{"key":"5639_CR38","doi-asserted-by":"publisher","first-page":"920","DOI":"10.2215\/CJN.08080520","volume":"15","author":"A Bagga","year":"2020","unstructured":"Bagga A, Sinha A (2020) Individualizing treatment of steroid-resistant nephrotic syndrome: registries to the fore. Clin J Am Soc Nephrol 15:920\u2013922","journal-title":"Clin J Am Soc Nephrol"},{"key":"5639_CR39","doi-asserted-by":"crossref","unstructured":"Lu L, Yap YC, Nguyen DQ, Chan YH, Ng JL, Zhang YC, Chan CY, Than M, Liu ID, Asim S, Moorani K, Naeem B, Ijaz I, Nguyen TMT, Lee ML, Eng C, Huque SS, Ng YH, Ganesan I, Chao SM, Chong SL, Tan PH, Loh A, Davila S, Kumar V, Ling JZ, Moorakonda RB, Tan KM, Ng AY, Poon KS, Schaefer F, Lipska-Zietkiewicz B, Yap HK, Ng KH, Deciphering Diversities: Renal Asian Genetics Network (DRAGoN) (2022) Multicenter study on the genetics of glomerular diseases among southeast and south Asians: Deciphering Diversities - Renal Asian Genetics Network (DRAGoN). Clin Genet 101:541\u2013551","DOI":"10.1111\/cge.14116"},{"key":"5639_CR40","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1053\/j.ajkd.2003.08.010","volume":"42","author":"G Filler","year":"2003","unstructured":"Filler G, Young E, Geier P, Carpenter B, Drukker A, Feber J (2003) Is there really an increase in non-minimal change nephrotic syndrome in children? Am J Kidney Dis 42:1107\u20131113","journal-title":"Am J Kidney Dis"},{"key":"5639_CR41","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/S2352-4642(18)30283-9","volume":"2","author":"K Tullus","year":"2018","unstructured":"Tullus K, Webb H, Bagga A (2018) Management of steroid-resistant nephrotic syndrome in children and adolescents. Lancet Child Adolesc Health 2:880\u2013890","journal-title":"Lancet Child Adolesc Health"},{"key":"5639_CR42","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.1681\/ASN.2016101121","volume":"28","author":"Trautmann A, Schnaidt S, Lipska-Zi\u0119tkiewicz BS, Bodria M, Ozaltin F, Emma F, Anarat A, Melk A, Azocar M, Oh J, Saeed B, Gheisari A, Caliskan S, Gellermann J, Higuita LMS, Jankauskiene A, Drozdz D, Mir S, Balat A, Szczepanska M, Paripovic D, Zurowska A, Bogdanovic R, Yilmaz A, Ranchin B, Baskin E, Erdogan O, Remuzzi G, Firszt-Adamczyk A, Kuzma-Mroczkowska E, Litwin M, Murer L, Tkaczyk M, Jardim H, Wasilewska A, Printza N, Fidan K, Simkova E, Borzecka H, Staude H, Hees K, Schaefer F; PodoNet Consortium","year":"2017","unstructured":"Trautmann A, Schnaidt S, Lipska-Zi\u0119tkiewicz BS, Bodria M, Ozaltin F, Emma F, Anarat A, Melk A, Azocar M, Oh J, Saeed B, Gheisari A, Caliskan S, Gellermann J, Higuita LMS, Jankauskiene A, Drozdz D, Mir S, Balat A, Szczepanska M, Paripovic D, Zurowska A, Bogdanovic R, Yilmaz A, Ranchin B, Baskin E, Erdogan O, Remuzzi G, Firszt-Adamczyk A, Kuzma-Mroczkowska E, Litwin M, Murer L, Tkaczyk M, Jardim H, Wasilewska A, Printza N, Fidan K, Simkova E, Borzecka H, Staude H, Hees K, Schaefer F; PodoNet Consortium (2017) Long-term outcome of steroid-resistant nephrotic syndrome in children. J Am Soc Nephrol 28:3055\u20133065","journal-title":"J Am Soc Nephrol"},{"key":"5639_CR43","doi-asserted-by":"publisher","unstructured":"Kemper MJ, Gibson K, Sinha A (2021) Nongenetic forms of steroid-resistant nephrotic syndrome. In: Emma F, Goldstein S, Bagga A, Bates CM, Shroff R (eds) Pediatric nephrology. Springer, Berlin, Heidelberg, pp. 1\u201325. https:\/\/doi.org\/10.1007\/978-3-642-27843-3_93-1","DOI":"10.1007\/978-3-642-27843-3_93-1"},{"key":"5639_CR44","doi-asserted-by":"crossref","unstructured":"Liu ID, Willis NS, Craig JC, Hodson EM (2019) Interventions for idiopathic steroid-resistant nephrotic syndrome in children. Cochrane Database Syst Rev 11:CD003594","DOI":"10.1002\/14651858.CD003594.pub6"},{"key":"5639_CR45","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1053\/j.ajkd.2008.11.033","volume":"53","author":"S Choudhry","year":"2009","unstructured":"Choudhry S, Bagga A, Hari P, Sharma S, Kalaivani M, Dinda A (2009) Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial. Am J Kidney Dis 53:760\u2013769","journal-title":"Am J Kidney Dis"},{"key":"5639_CR46","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4103\/0971-4065.107197","volume":"23","author":"A Sinha","year":"2013","unstructured":"Sinha A, Sharma A, Mehta A, Gupta R, Gulati A, Hari P, Dinda AK, Bagga A (2013) Calcineurin inhibitor induced nephrotoxicity in steroid resistant nephrotic syndrome. Indian J Nephrol 23:41\u201346","journal-title":"Indian J Nephrol"},{"key":"5639_CR47","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.kint.2017.01.019","volume":"92","author":"A Sinha","year":"2017","unstructured":"Sinha A, Gupta A, Kalaivani M, Hari P, Dinda AK, Bagga A (2017) Mycophenolate mofetil is inferior to tacrolimus in sustaining remission in children with idiopathic steroid-resistant nephrotic syndrome. Kidney Int 92:248\u2013257","journal-title":"Kidney Int"},{"key":"5639_CR48","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00467-018-4166-1","volume":"35","author":"K Kamei","year":"2020","unstructured":"Kamei K, Ishikura K, Sako M, Ito S, Nozu K, Iijima K (2020) Rituximab therapy for refractory steroid-resistant nephrotic syndrome in children. Pediatr Nephrol 35:17\u201324","journal-title":"Pediatr Nephrol"},{"key":"5639_CR49","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1681\/ASN.2018010091","volume":"29","author":"H Trachtman","year":"2018","unstructured":"Trachtman H, Nelson P, Adler S, Campbell KN et al (2018) DUET: a phase 2 study evaluating the efficacy and safety of sparsentan in patients with FSGS. J Am Soc Nephrol 29:2745\u20132754","journal-title":"J Am Soc Nephrol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-022-05639-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-022-05639-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-022-05639-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T23:14:34Z","timestamp":1727478874000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-022-05639-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,28]]},"references-count":49,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["5639"],"URL":"https:\/\/doi.org\/10.1007\/s00467-022-05639-6","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,28]]},"assertion":[{"value":"8 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}